XFLH · XFLH Capital Corp · Documents

$10.16 -0.01 (-0.10%) At close · Nov 12

Market Cap

$141.11M

13.89M

Volume · Nov 12 1045 Avg daily vol (3M) 14.86K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Quarterly report FY2026 Q3 Net income $757.75K 10-Q filed Jul 13, 2026

2026

Sep 22

Current report 8-K Events of Sep 18

Entered into a material agreement, Other events

XFLH Capital Corporation signed a non-binding letter of intent with Renogen Biolab Inc. for a proposed business combination, with both parties committed to good-faith negotiations of definitive agreements and due diligence.

Jul 13

Quarterly report 10-Q FY2026 Q3, ended May 31

Quarterly report for FY2026 Q3 AI summary on its way

Net income $757.75K Diluted EPS -$0.01

Apr 14

Quarterly report 10-Q FY2026 Q2, ended Feb 28

Quarterly report for FY2026 Q2 AI summary on its way

Net income $42.2K Diluted EPS -$0.01

Mar 4

Current report 8-K

Other events AI summary on its way

Feb 20

Current report 8-K Events of Feb 13

Other events AI summary on its way

Feb 17

Current report 8-K Events of Feb 11

Entered into a material agreement, Unregistered sale of equity, Charter or bylaw amendment, or fiscal year change, Other events AI summary on its way

Jan 30

Registration statement S-1/A

Registration statement AI summary on its way

Jan 26

Registration statement S-1/A

Registration statement AI summary on its way

Jan 13

Registration statement S-1/A

Registration statement AI summary on its way

2025

Dec 23

Registration statement S-1/A

Registration statement

Dec 5

Registration statement S-1/A

Registration statement

Sep 29

Registration statement S-1

Registration statement

Showing 1–12 of 12 documents

Key facts CIK 2088103 CUSIP G9834D107 13F (30d) 7 filings 7 filers